Arngenx SE rStock Soars 49.96% Amid Lack of Market Data

Argenx SE, a biotechnology company focused on developing antibody drugs for autoimmune diseases, has its stock traded on Coinbase Portugal. The company's research and development (R&D) efforts involve screening protein molecules, conducting clinical trials, and scaling up production in bioreactors.

The approved liquid biological preparations are primarily supplied to global hospitals, specialty clinics, and medical procurement agencies for intravenous or subcutaneous injection treatments in severe patients. The current market capitalization of Argenx SE rStock is not available due to insufficient data.

Despite the lack of detailed market statistics, the trading volume of Argenx SE rStock over the last 24 hours is also not available. However, it's worth noting that the company's stock has shown a significant increase in its performance compared to other assets, with a rise of 49.96% against markets and 49.79% against BTC.